SCHEMBL4379922

SCHEMBL4379922

C(=CCOCC=CCCCc1c[nH]cn1)CCCc1c[nH]cn1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4389331 0.81
SCHEMBL4392989 0.79
SCHEMBL5322896 0.75 HRH4 (0.32)
SCHEMBL22541334 0.75 CDK1 (0.32)
SCHEMBL4389334 0.73 HRH4 (0.36)
SCHEMBL4392986 0.72
SCHEMBL8934804 0.72
SCHEMBL4386652 0.72 HRH3 (0.31)
SCHEMBL9999610 0.71
SCHEMBL4384776 0.71 HRH4 (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0760811-B1 IMIDAZOLE DERIVATIVES AS HISTAMINE RECEPTOR H3 MODULATORS INST NAT SANTE RECH MED (FR) 2009-11-18 EP claimed
WO-1996029315-A2 IMIDAZOLE DERIVATIVES AS HISTAMINE RECEPTOR H3 (ANT)AGONISTS INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (FR) 1996-09-26 WO disclosed